| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |